Overview


According to FutureWise analysis the market for biophotonics in 2023 is US$ 58.59 billion, and is expected to reach US$ 140.17 billion by 2031 at a CAGR of 11.50%.

Biophotonics is a fascinating field that combines biology, physics, and engineering to study biological systems using light-based technologies. It involves the use of photonics-based techniques such as lasers, fluorescence, and imaging to analyze biological molecules, cells, and tissues. Biophotonics has gained significant importance in recent years due to its potential use in various industries, including medical diagnostics and treatment, environmental monitoring, and food safety.

Biophotonics-based technologies are used for non-invasive imaging and diagnosis of diseases, drug discovery, and development, and targeted drug delivery in medical diagnostics and treatment. For instance, fluorescence-based imaging techniques are used for real-time visualization of cellular processes and tissues, while laser-based technologies are used for precision surgery and treatment of cancer. In environmental monitoring, biophotonics-based technologies are used to detect and analyze environmental contaminants such as pollutants and pathogens. For example, fluorescence-based sensors are used to detect heavy metals in water, while Raman spectroscopy is used to identify microorganisms in food and water samples. Furthermore, biophotonics has promising applications in the field of food safety, where it can be used for the identification of microorganisms and the detection of contaminants in food products. Biophotonics-based techniques in food safety can improve food quality and reduce the risk of foodborne illnesses.

FutureWise Market Research has published a report that provides an insightful analysis of Biophotonics Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. By the end of the forecast period FutureWise research analysts projects that Biophotonics Market will experience a significant growth.

According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic and expansion decisions by key stakeholders of an organization.

  • Affymetrix, Inc.
  • Andor Technology Ltd
  • Becton, Dickinson and Company
  • Carl Zeiss AG
  • FEI Company
  • Hamamatsu Photonics K.K.
  • Lumenis Ltd.
  • Olympus Corporation
  • Perkinelmer, Inc.
  • Zecotek Photonics Inc.

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent developments by key players in Biophotonics Market:

  • In November 2021, Oxford Instruments unveiled the BC43, a portable microscope. This tool allows users to see 3D images in real time.

The Biophotonics Market is driven by several factors, including the increasing demand for non-invasive diagnostic and imaging techniques, the growing prevalence of chronic diseases, and the rising adoption of biophotonics in research and development activities. Additionally, the technological advancements in photonics and the development of innovative products are also driving the market's growth. One of the primary market drivers is the increasing demand for non-invasive diagnostic and imaging techniques. Biophotonics-based imaging and diagnostic technologies offer several advantages over traditional techniques, such as improved accuracy, speed, and safety. These techniques also enable early detection and monitoring of diseases, which is critical in improving patient outcomes and reducing healthcare costs. The increasing frequency of chronic illnesses, such as diabetes, cancer, cardiovascular diseases, and neurological disorders, also drives the demand for biophotonics-based diagnostic and imaging technologies. Biophotonics-based techniques are being increasingly used for disease diagnosis, monitoring, and treatment planning, as they provide accurate and detailed information about the structure and function of tissues and cells. Moreover, the rising adoption of biophotonics in research and development activities drives the market's growth. Biophotonics-based technologies are widely used in life sciences research, drug discovery, and development, as they enable non-invasive imaging and analysis of biological systems and processes. The technological advancements in photonics and the development of innovative products are also driving the growth of the Biophotonics Market. For instance, the development of advanced imaging and sensing technologies, such as optical coherence tomography (OCT), fluorescence imaging, and Raman spectroscopy, has expanded the applications of biophotonics in healthcare and life sciences.

However, the high cost of biophotonics-based technologies is one of the major challenges the Biophotonics Market faces. Developing and manufacturing advanced biophotonics-based devices and systems require high capital investment, which translates to high prices for end-users. This may limit the adoption of biophotonics-based technologies, particularly in developing countries with low healthcare expenditures.

By Application

  • See-Through Imaging
  • Inside Imaging (Endoscopy)
  • Spectro molecular
  • Surface Imaging
  • Microscopy
  • Light Therapy
  • Biosensors
  • Others

By Technology

  • In-Vivo
  • In-Vitro

By End Use

  • Medical Diagnostics
  • Medical Therapeutics
  • Test Components
  • Other (Non-Medical)

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered the highest share in the market in 2022. North America currently dominates the biophotonics industry, and this dominance is anticipated to continue over the forecast period. The biophotonics sector's biggest market is the United States. The growth of nanotechnology has also been a major factor in the U.S. biophotonics sector. The tremendous technological advancements have increased the importance of optical approaches in addressing medical and life science-related issues. Optical technology is employed in many different contexts, such as the therapeutic treatment of patients and molecular-level research. An increasing number of conferences are being held in the U.S. to examine the developments in biophotonics and other optical approaches. As a result, these initiatives may contribute to the biophotonics market's expansion in North America over the projected period.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Biophotonics Market By Application, By Technology, By End Use and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Global Biophotonics Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Biophotonics Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Biophotonics Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Biophotonics Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. See-Through Imaging
        2. Inside Imaging (Endoscopy)
        3. Spectro molecular
        4. Surface Imaging
        5. Microscopy
        6. Light Therapy
        7. Biosensors
        8. Others

  • 8.   Global Biophotonics Market, By Technology Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. In-Vivo
        2. In-Vitro

  • 9.   Global Biophotonics Market, By End Use Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Medical Diagnostics
        2. Medical Therapeutics
        3. Test Components
        4. Other (Non-Medical)

  • 10.   North America Biophotonics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Biophotonics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Biophotonics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Biophotonics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Affymetrix, Inc.
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Andor Technology Ltd
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Becton, Dickinson And Company
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Carl Zeiss AG
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. FEI Company
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Hamamatsu Photonics K.K.
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Lumenis Ltd.
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Olympus Corporation
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Perkinelmer, Inc.
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Zecotek Photonics Inc.
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients